Literature DB >> 24157962

Hemochromatosis and iron overload: from bench to clinic.

James C Barton1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24157962     DOI: 10.1097/MAJ.0000000000000192

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  6 in total

1.  New developments and controversies in iron metabolism and iron chelation therapy.

Authors:  Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2016-03-26

Review 2.  Bacterial iron-sulfur cluster sensors in mammalian pathogens.

Authors:  Halie K Miller; Victoria Auerbuch
Journal:  Metallomics       Date:  2015-06       Impact factor: 4.526

3.  Neutrophils from hereditary hemochromatosis patients are protected from iron excess and are primed.

Authors:  Cyril Renassia; Sabine Louis; Sylvain Cuvellier; Nadia Boussetta; Jean-Christophe Deschemin; Didier Borderie; Karine Bailly; Joel Poupon; Pham My-Chan Dang; Jamel El-Benna; Sandra Manceau; François Lefrère; Sophie Vaulont; Carole Peyssonnaux
Journal:  Blood Adv       Date:  2020-08-25

Review 4.  Pathophysiological consequences and benefits of HFE mutations: 20 years of research.

Authors:  Ina Hollerer; André Bachmann; Martina U Muckenthaler
Journal:  Haematologica       Date:  2017-03-09       Impact factor: 9.941

5.  The microbiome and inborn errors of metabolism: Why we should look carefully at their interplay?

Authors:  Karina Colonetti; Luiz Fernando Roesch; Ida Vanessa Doederlein Schwartz
Journal:  Genet Mol Biol       Date:  2018 Jul/Sept.       Impact factor: 1.771

6.  Increased Retinal Expression of the Pro-Angiogenic Receptor GPR91 via BMP6 in a Mouse Model of Juvenile Hemochromatosis.

Authors:  Pachiappan Arjunan; Jaya P Gnanaprakasam; Sudha Ananth; Michelle A Romej; Veeranan-Karmegam Rajalakshmi; Puttur D Prasad; Pamela M Martin; Mariappan Gurusamy; Muthusamy Thangaraju; Yangzom D Bhutia; Vadivel Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.